ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Lurasidone Pediatric Autism Study

ClinicalTrials.gov ID: NCT01911442

Public ClinicalTrials.gov record NCT01911442. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 11:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Irritability Associated With Autistic Disorder

Study identification

NCT ID
NCT01911442
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
150 participants

Conditions and interventions

Conditions

Interventions

  • Lurasidone Drug
  • Lurasidone 20 mg daily Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2013
Primary completion
Oct 31, 2014
Completion
Oct 31, 2014
Last update posted
Feb 24, 2016

2013 – 2014

United States locations

U.S. sites
41
U.S. states
24
U.S. cities
41
Facility City State ZIP Site status
Harmonex Neuroscience Research Dothan Alabama 36303
Southwest Autism Research & Resource Center Phoenix Arizona 85006
Newport Beach Clinical Research Associates Newport Beach California 92663
University of California San Francisco Medical Center San Francisco California 94143
Florida Clinical Research Center, LLC Bradenton Florida 34201
Sarkis Clinical Trials - Parent Gainesville Florida 32607
Palm Springs Research Institute Inc Hialeah Florida 33012
Florida Clinical Research Center, LLC Maitland Florida 32751
Clinical Neuroscience Solutions, Inc. Orlando Florida 32806
Medical Research Group of Central Florida Sanford Florida 32771
University of South Florida St. Petersburg Florida 33701
University of South Florida Tampa Florida 33613-4706
Institute for Behavioral Medicine, LLC Smyrna Georgia 30080
Capstone Clinical Research, Inc. Libertyville Illinois 60048
Baber Research Group Naperville Illinois 60563
University of Kentucky Lexington Kentucky 40509
Lake Charles Clinical Trials, LLC Lake Charles Louisiana 70629
Kennedy Krieger Institute Baltimore Maryland 21287
NeuroScientific Insights Rockville Maryland 20852
Neurobehaviorial Medicine Group, PLLC Bloomfield Hills Michigan 48302
Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas Nevada 89128
Jersey Shore University Medical Center Neptune City New Jersey 07753
Childrens Specialized Hospital Toms River New Jersey 08755
Finger Lakes Clinical Research Rochester New York 14618
Richmond Behavioral Associates Staten Island New York 10312
Montefiore Medical Center PRIME The Bronx New York 10467
Chapel Hill Neurology Chapel Hill North Carolina 27517
University Hospitals Case Medical Center Cleveland Ohio 44106
The Ohio State University Nisonger Center Columbus Ohio 43210
Cutting Edge Research Group Oklahoma City Oklahoma 73116
Cyn3rgy Research & Development Gresham Oregon 97030
Suburban Research Associates Media Pennsylvania 19063
Segal Institute for Clinical Research Charleston South Carolina 29407
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119
Family Psychiatry of The Woodlands, P.A. The Woodlands Texas 77381
Ericksen Research & Development, LLC Clinton Utah 84015
CRI Lifetree Salt Lake City Utah 84106
University of Virginia Charlottesville Virginia 22903
Neuroscience, Inc. Herndon Virginia 20170
Carilion Clinic Roanake Virginia 24014
Pacific Institute of Medical Sciences Bothell Washington 98011

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01911442, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 24, 2016 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01911442 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →